Introduction

Results
FimAECO, FimASHI, and FimASAL fold to self-complemented monomers via intramolecular, parallel donor strand complementation

Protein crystal | FimA E. coli | FimA S. flexneri | FimA S. enterica |
---|---|---|---|
PDB code | 5NKT | 5LP9 | 6ERJ |
Data collection | |||
Space group | H 3 2 | P 1 21 1 | C 2 2 21 |
Cell dimensions | |||
a, b, c (Å) | 87.0, 87.0, 162.7 | 24.1, 53.8, 50.3 | 35.0, 104.4, 182.9 |
α, β, γ (°) | 90, 90, 120 | 90, 100.3, 90 | 90, 90, 90 |
Resolution (Å) | 29.87–1.50 (1.55–1.50) | 26.89–0.89 (0.92–0.89) | 45.72–1.69 (1.73–1.69) |
Rmeas (%) | 5.5 (160.2) | 4.4 (56.7) | 12.2 (216.9) |
I/σ(I) | 20.0 (1.1) | 20.9 (2.5) | 12.1 (1.3) |
Anisotropy | 0.437 | 0.122 | 0.276 |
CC1/2 | 99.9 (47.2) | 99.9 (80.6) | 99.9 (43.9) |
Redundancy | 9.4 (5.9) | 6.2 (4.0) | 15.2 (11.0) |
Completeness (%) | 98.8 (89.3) | 91.0 (84.3) | 98.6 (81.5) |
Resolution I/σ(I) >2 (Å) | 1.58 | 0.89 | 1.78 |
Refinement | |||
Resolution (Å) | 29.87–1.50 | 26.89–0.89 | 45.72–1.69 |
No. unique reflections | 37,771 | 88,551 | 37,847 |
Rwork, Rfree (%) | 15.8, 18.8 | 11.0, 12.6 | 17.2, 23.7 |
No. atoms | 1,237 | 1,679 | 2,474 |
Protein | 1,059 | 1,446 | 2,241 |
Ligand | 25 | 12 | |
Water | 153 | 233 | 221 |
Average B-factors (Å2) | 44.3 | 14.9 | 39.5 |
Protein | 43.4 | 13.3 | 38.5 |
Ligand | 56.1 | 58.6 | |
Water | 48.5 | 24.7 | 48.5 |
Wilson B-factor (Å2) | 26.2 | 8.3 | 28.7 |
RMSD | |||
Bond lengths (Å) | 0.004 | 0.007 | 0.009 |
Bond angles (°) | 0.66 | 1.05 | 0.85 |
Ramachandran statistics | |||
Favored regions (%) | 97.96 | 94.30 | 97.46 |
Allowed regions (%) | 2.04 | 5.70 | 2.54 |
Outliers (%) | 0 | 0 | 0 |
Folding and stability of FimAECO, FimASHI, and FimASAL compared with their FimAa counterparts

FimAECO | FimASHI | FimASAL | FimAaECO | FimAaSHI | FimAaSAL | |
---|---|---|---|---|---|---|
ΔG0(kJ mol−1) | −5.5 ± 0.5 | − 8.9 ± 0.5 | −7.2 ± 2.0 | −66.5 ± 2.8 | −62.4 ± 1.4 | −67.7 ± 1.4 |
meq (kJ mol−1 m−1) | 23.0 ± 1.3 | 18.5 ± 1.0 | 18.8 ± 2.5 | 25.7 ± 0.9 | 21.9 ± 0.4 | 21.3 ± 0.4 |
D1/2, eq (m GdnHCl) | 0.24 | 0.49 | 0.38 | 2.59 | 2.85 | 3.18 |
teq | <1 day | <1 day | <1 day | 3225 years | 978 years | 273 years |
ΔG0(Aa)/ΔG0(Awt) | 12.0 | 7.0 | 9.4 | |||
kFH2O (s−1) | 7.5 ± 1.9 × 10−5 | 1.3 ± 0.2 × 10−4 | 5.5 ± 0.8 × 10−4 | |||
mF (m−1) | −6.3 ± 0.3 | −5.5 ± 0.1 | −5.0 ± 0.1 | |||
kU H2O (s−1) | 1.6 ± 1.8 × 10−16 | 1.5 ± 0.8 × 10−16 | 7.5 ± 4.1 × 10−16 | |||
mU (m−1) | 4.1 ± 0.2 | 3.4 ± 0.1 | 3.6 ± 0.1 | |||
D1/2, kin(m GdnHCl) | 2.6 ± 0.1 | 2.9 ± 0.1 | 3.2 ± 0.1 | |||
α = (mF/(mU − mF)) | 0.60 ± 0.02 | 0.62 ± 0.01 | 0.58 ± 0.01 |


The FimA donor strand does not contribute to the transition state of FimA folding

FimA construct | Measured kF in 60 mm GdnHCl (s−1) | Calculated kF in 60 mm GdnHCl (s−1) | (kcalcF)/(kmeasuredF) | (kF(FimA))/(kF(FimAa)) |
---|---|---|---|---|
FimAECO | 9.50 ± 0.08 × 10−5 | NA | 1.03 | |
FimAaECO | 9.26 ± 0.09 × 10−5 | 1.09 ± 0.28 × 10−4 | 1.18 | |
FimASHI | 2.08 ± 0.01 × 10−4 | NA | 1.32 | |
FimAaSHI | 1.57 ± 0.01 × 10−4 | 1.81 ± 0.28 × 10−4 | 1.15 | |
FimASAL | 1.05 ± 0.01 × 10−3 | NA | 0.97 | |
FimAaSAL | 1.08 ± 0.02 × 10−3 | 7.42 ± 1.09 × 10−4 | 0.69 |
Discussion
Materials and methods
Primary structures of the FimA constructs used
Protein expression and purification
Protein concentrations
GdnHCl-dependent unfolding and refolding transitions
where fN(t) is the fraction of native molecules after incubation time t, kFH2O and kUH2O are the rate constants of folding and unfolding in the absence of denaturant, mF and mU are the linear dependences of ln(kU) and ln(kF) on GdnHCl concentration, and D is the GdnHCl concentration. The parameter fN(0) is zero for unfolding and one for refolding experiments. Equation 3 describes the kinetics of attainment of a two-state folding equilibrium, and Equations 1 and 2 describe the dependence of kF and kU on denaturant concentration, respectively. Replacement of kF and kU in Equation 3 by their denaturant dependences (Equations 2 and 3) yields the fraction of native molecules fN(t) as a function of fN(0), D, kFH2O, kUH2O, mF, mU, and incubation time t. As the folding equilibria of the FimAa constructs could not be attained, kU dominated over kF in the transition regions of unfolding, and kF dominated in the transitions regions of refolding. Therefore, kF was set to zero for global fitting of the three unfolding transitions recorded for each FimAa construct, and kU was set to zero for global fitting of the three refolding transitions. For normalization of the recorded CD signals, Equation 4 was used,
where S is the measured CD signal, SN0 and SU0 are the signals of the folded and unfolded protein at zero denaturant, respectively, and mN and mU are the linear dependences of the signals of the folded and unfolded protein on D, respectively. For the refolding transitions of all FimAa constructs, mN was set to zero due to the absence of a pre-transition baseline.
where ΔG0H2O is the free energy of folding at zero denaturant and meq is the cooperativity of folding (in J mol−1 m−1), which equals (mU − mF) × RT.
Protein crystallization and X-ray data collection
Structure solution and refinement
Accession numbers
Limited proteolysis of FimA and FimAa
Author contributions
Acknowledgments
Supplementary Material
References
- Structure and function of Escherichia coli type 1 Pili: new insight into the pathogenesis of urinary tract infections.J. Infect. Dis. 2001; 183 (11171011): S36-S40
- Bacterial adhesion and entry into host cells.Cell. 2006; 124 (16497583): 715-727
- A comprehensive guide to pilus biogenesis in Gram-negative bacteria.Nat. Rev. Microbiol. 2017; 15 (28496159): 365-379
- Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.FEMS Microbiol. Rev. 2012; 36 (22545799): 1046-1082
- Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.Proc. Natl. Acad. Sci. U.S.A. 1996; 93 (8790416): 9827-9832
- Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice; Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.J. Clin. Invest. 1985; 75 (2857730): 347-360
- Waging war against uropathogenic Escherichia coli: winning back the urinary tract.Infect. Immun. 2010; 78 (19917708): 568-585
- Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor.Cell. 2001; 105 (11440716): 733-743
- Catch-bond mechanism of the bacterial adhesin FimH.Nat Commun. 2016; 7: 10738
- Molecular mechanism of bacterial type 1 and P pili assembly.Philos. Trans. R. Soc. A Math. Phys. Eng. Sci. 2015; 373 (20130153, 10.1098/rsta.2013.0153): 20130153
- The cryoelectron microscopy structure of the type 1 chaperone-usher pilus rod.Structure. 2017; 25 (29129382): 1829-1838.e4
- Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions.Elife. 2018; 7 (29345620): e31662
- Intramolecular donor strand complementation in the E. coli type 1 pilus subunit fima explains the existence of fima monomers as off-pathway products of pilus assembly that inhibit host cell apoptosis.J. Mol. Biol. 2014; 426 (24184277): 542-549
- Structure, folding and stability of FimA, the main structural subunit of type 1 Pili from uropathogenic Escherichia coli strains.J. Mol. Biol. 2011; 412 (21816158): 520-535
- Pilus biogenesis at the outer membrane of Gram-negative bacterial pathogens.Curr. Opin. Struct. Biol. 2012; 22 (22402496): 500-506
- Reconstitution of pilus assembly reveals a bacterial outer membrane catalyst.Science. 2008; 320 (10.1126/science.1154994): 376-379
- Infinite kinetic stability against dissociation of supramolecular protein complexes through donor strand complementation.Structure. 2008; 16 (18400183): 631-642
- Chaperone-independent folding of type 1 pilus domains.J. Mol. Biol. 2002; 322 (12270717): 827-840
- Pilus chaperones represent a new type of protein-folding catalyst.Nature. 2004; 431 (15372038): 329-333
- Quality control of disulfide bond formation in pilus subunits by the chaperone FimC.Nat. Chem. Biol. 2012; 8 (22772153): 707-713
- A soluble form of the pilus protein FimA targets the VDAC-hexokinase complex at mitochondria to suppress host cell apoptosis.Mol. Cell. 2010; 37 (20347420): 768-783
- OLDERADO: On-line database of ensemble representatives and domains.Protein Sci. 1997; 6 (9416612): 2628-2630
- Quantitative analysis of nonequilibrium, denaturant-dependent protein folding transitions.J. Am. Chem. Soc. 2007; 129 (17602628): 8938-8939
- Dissociation and reassembly of Escherichia coli type 1 pili.J. Bacteriol. 1981; 148 (6116696): 308-314
- W. H. Freeman, New York, NY1998 Structure and mechanism in protein science: a guide to enzyme catalysis and protein folding.
- Mechanism of fibre assembly through the chaperone-usher pathway.EMBO Rep. 2006; 7 (16767077): 734-738
- Features and development of Coot.Acta Crystallogr. Sect. D Biol. Crystallogr. 2010; 66 (10.1107/S0907444910007493): 486-501
- SignalP 4.0: discriminating signal peptides from transmembrane regions.Nat. Methods. 2011; 8 (21959131): 785-786
- PapD-like chaperones provide the missing information for folding of pilin proteins.Proc. Natl. Acad. Sci. U.S.A. 2000; 97 (10859353): 7709-7714
- Humana Press, Totowa, New Jersey2005 The Proteomics Protocols Handbook.
- The preparation of guanidine hydrochloride.Methods Enzymol. 1972; 26 (4680720): 43-50
- XDS Acta Crystallogr. Sect. D Biol. Crystallogr. 2010; 66: 125-132
- Phaser crystallographic software.J. Appl. Crystallogr. 2007; 40 (19461840): 658-674
- PHENIX: A comprehensive Python-based system for macromolecular structure solution.Acta Crystallogr. Sect. D Biol. Crystallogr. 2010; 66 (20124702): 213-221
Article info
Publication history
Footnotes
This work was supported by Swiss National Science Foundation Grants 310030B_176403/1 and 31003A_156304 (to R. G.). The authors declare that they have no conflicts of interest with the contents of this article.
This article contains Figs. S1–S3.
The atomic coordinates and structure factors (codes 5NKT, 5LP9, and 6ERJ) have been deposited in the Protein Data Bank (http://wwpdb.org/).
Identification
Copyright
User license
Creative Commons Attribution (CC BY 4.0) |
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy